However, when subdivided by stage, early-stage colorectal cancer patients with TYW2 low expression levels showed significantly reduced overall survival (HR = 4.78; 95% CI = 2.03 to 11.27; P < 0.001, log-rank test) (SI Appendix, Fig. S13B). The gene discussed is TYW2; the disease is colorectal cancer.